Status:

COMPLETED

Efficacy Study of LV Assist Device to Treat Patients With Cardiogenic Shock (ISAR-SHOCK)

Lead Sponsor:

Deutsches Herzzentrum Muenchen

Collaborating Sponsors:

Abiomed Inc.

Conditions:

Shock, Cardiogenic

Myocardial Infarction

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of this study is to evaluate the efficacy and safety of a left ventricular assist device in comparison to a standard treatment with an intraaortic balloon pump (IABP) in patients with card...

Detailed Description

Cardiogenic shock due to a left ventricular failure after myocardial infarction (MI) is associated with a mortality rate of 50-70 % despite all efforts such as immediate PCI of the occluded vessel, po...

Eligibility Criteria

Inclusion

  • Acute coronary syndrome (ACS/AMI) \< 48h and cardiogenic shock defined as:
  • Clinical criteria: Hypotension (syst.BP \< 90 mmHg and HR \> 90/min or an AV- Block II-III) or the need for positive inotropic drugs to maintain BB \> 90mm Hg)and end-organ hypoperfusion
  • Hemodynamic criteria: CI \< 2.2 L/min/qm and a PCWP \> 15 mmHg or an EF of LV \< 30% and LVEDP \> 20 mmHg.
  • Written informed consent of the patient or his/hers relatives

Exclusion

  • Age \< 18 years
  • Prolonged Resuscitation (\> 30min)
  • Hypertrophic Obstructive Cardiomyopathy
  • Thrombus in left ventricle
  • Treatment with IABP
  • Severe valvular disease or mechanical heart valve
  • Cardiogenic Shock due to mechanical complications of myocardial infarction such as VSD, acute mitral regurgitation \>II°, rupture of the ventricle
  • Failure of the right ventricle defined as the need for a RV Assist Device
  • Septic condition
  • Cerebral Disease
  • Bleeding with a need for surgical intervention
  • Pulmonary embolism
  • Allergy to Heparin or any known coagulopathy
  • Aortic regurgitation \>II°
  • Pregnancy
  • Inclusion in another study or trial

Key Trial Info

Start Date :

August 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2006

Estimated Enrollment :

26 Patients enrolled

Trial Details

Trial ID

NCT00417378

Start Date

August 1 2004

End Date

March 1 2006

Last Update

November 28 2007

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Deutsches Herzzentrum Muenchen

Munich, Germany, 80636

2

1. Medizinische Klinik, Klinikum rechts der Isar

Munich, Germany, 81675